Form C-AR - Annual Report:
SEC Accession No. 0001665160-25-000999
Filing Date
2025-05-06
Accepted
2025-05-05 18:30:59
Documents
2
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C-AR  
1 primary_doc.xml C-AR 3486
2 form_car.pdf EX-99 25110042
  Complete submission text file 0001665160-25-000999.txt   33976539
Mailing Address 5950 BERKSHIRE LN., SUITE 375 DALLAS TX 75225
Business Address 5950 BERKSHIRE LN, STE 375 DALLAS TX 75225 214-389-1748
Berkshire Biomedical Corp (Filer) CIK: 0002048576 (see all company filings)

EIN.: 873054745 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C-AR | Act: 33 | File No.: 020-35585 | Film No.: 25914564